Kaohsiung, Taiwan

Hsin-Ju Chien


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hsin-Ju Chien: Innovator in Anti-Bacterial and Cancer Treatment

Introduction

Hsin-Ju Chien is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of medical science, particularly in the development of treatments for bacterial infections and leukemia. His innovative work has the potential to impact the healthcare industry positively.

Latest Patents

Hsin-Ju Chien holds a patent for an "Anti-bacterial infection, inflammation, and leukemia composition and use thereof." This patent describes a method of inhibiting the growth of Gram-positive bacteria by administering an effective amount of Tellimagrandin II, along with its pharmaceutically acceptable salt, enantiomer, isomer, or tautomer. The method specifically targets methicillin-resistant bacteria. Additionally, it outlines a method for treating sepsis and leukemia using the same compound, showcasing its versatility and therapeutic potential.

Career Highlights

Hsin-Ju Chien is affiliated with Kaohsiung Medical University, where he conducts research and develops innovative medical solutions. His work is characterized by a commitment to addressing critical health challenges through scientific inquiry and invention.

Collaborations

Hsin-Ju Chien collaborates with esteemed colleagues, including Lih-Geeng Chen and Yen-Hsu Chen. These partnerships enhance the research and development process, fostering an environment of innovation and shared expertise.

Conclusion

Hsin-Ju Chien's contributions to medical science, particularly through his patent on anti-bacterial and cancer treatment methods, highlight his role as a significant inventor in the field. His work not only addresses pressing health issues but also paves the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…